Search
Rocket Pharmaceuticals Inc
RCKTAdd to Watchlist
3.250USD
+0.010+0.31%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
352.04MMarket Cap
LossP/E TTM
Rocket Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-26The current valuation score of Rocket Pharmaceuticals Inc is 6.72, ranking 294 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.73, which is -48.75% below the recent high of -0.89 and -506.72% above the recent low of -10.52.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
